Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Does the glucagon-like peptide-1 receptor agonist semaglutide prevent deterioration of metabolic state in prediabetic or diabetic patients with schizophrenia treated with the antipsychotic compounds clozapine or olanzapine?

Project: Types of projectsProject

  • Fink-Jensen, Anders (Project Manager, academic)
  • Sass, Marie Reeberg (Project participant)
  • Storgaard, Heidi (Project participant)
  • Vilsbøll, Tina (Project participant)
  • Knop, Fillip (Project participant)
  • Nielsen, Mette Odegaard (Project participant)
  • Sjödin, Anders Mikael (Project participant)
  • Ekstrøm, Claus (Project participant)
  • Nielsen, Jimmi (Project participant)
  • Correll, Christopher (Project participant)
View graph of relations
StatusCurrent
Period01/03/202131/01/2024

ID: 61947959